1. Home
  2. WINT vs FAMI Comparison

WINT vs FAMI Comparison

Compare WINT & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WINT
  • FAMI
  • Stock Information
  • Founded
  • WINT 1992
  • FAMI 2015
  • Country
  • WINT United States
  • FAMI China
  • Employees
  • WINT N/A
  • FAMI N/A
  • Industry
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • FAMI Packaged Foods
  • Sector
  • WINT Health Care
  • FAMI Consumer Staples
  • Exchange
  • WINT Nasdaq
  • FAMI Nasdaq
  • Market Cap
  • WINT 2.2M
  • FAMI 2.2M
  • IPO Year
  • WINT 1995
  • FAMI 2018
  • Fundamental
  • Price
  • WINT $0.49
  • FAMI $1.81
  • Analyst Decision
  • WINT Hold
  • FAMI
  • Analyst Count
  • WINT 1
  • FAMI 0
  • Target Price
  • WINT $350.00
  • FAMI N/A
  • AVG Volume (30 Days)
  • WINT 7.2M
  • FAMI 18.9K
  • Earning Date
  • WINT 08-18-2025
  • FAMI 08-08-2025
  • Dividend Yield
  • WINT N/A
  • FAMI N/A
  • EPS Growth
  • WINT N/A
  • FAMI N/A
  • EPS
  • WINT N/A
  • FAMI N/A
  • Revenue
  • WINT N/A
  • FAMI $64,131,332.00
  • Revenue This Year
  • WINT N/A
  • FAMI N/A
  • Revenue Next Year
  • WINT N/A
  • FAMI N/A
  • P/E Ratio
  • WINT N/A
  • FAMI N/A
  • Revenue Growth
  • WINT N/A
  • FAMI N/A
  • 52 Week Low
  • WINT $0.36
  • FAMI $1.43
  • 52 Week High
  • WINT $737.44
  • FAMI $7.92
  • Technical
  • Relative Strength Index (RSI)
  • WINT 35.91
  • FAMI 50.59
  • Support Level
  • WINT $0.52
  • FAMI $1.74
  • Resistance Level
  • WINT $0.64
  • FAMI $1.94
  • Average True Range (ATR)
  • WINT 0.09
  • FAMI 0.12
  • MACD
  • WINT -0.00
  • FAMI -0.00
  • Stochastic Oscillator
  • WINT 14.12
  • FAMI 34.62

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

Share on Social Networks: